BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4.

Front Pharmacol · 2025 · PMC12328348 · PMID 40777995

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

This analysis revealed a clear trend wherein HGSOC tissues with low BCL6 expression had higher PLAAT4 expression, while the reverse was true for HGSOC tissues with high BCL6 expression ( Figures 6E,F ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.